Voici les éléments 1-5 de 5
Chroniques génomiques - L’invasion des tests non invasifs
(EDP Sciences, 2014)
Non-invasive prenatal testing is becoming commonplace, but, in addition, other tests using only a blood sample are being developed and will have a significant impact, notably in oncology.
Chroniques génomiques : Les points critiques du séquençage clinique
(Éditions EDK/Groupe EDP Sciences, 2012)
Chroniques Génomiques - Les chimères du dépistage
(Éditions EDK, Groupe EDP Sciences, 2017)
The use of circulating tumour DNA to screen for cancer in asymptomatic individuals is the goal of Grail, initially set up by Illumina. This company is now raising a large amount of capital to develop this project on a much ...
Recherche cibles, désespérément : Chroniques génomiques
(Éditions EDK, Groupe EDP Sciences, 2015)
In clinical oncology, obtaining sequence data from tumour samples has become practical in terms of logistics, turnover time and costs. The major issue now is the interpretation of this sequence to define actionable targets, ...
Chroniques génomiques - Dépister les cancers asymptomatiques ?
(EDP Sciences, 2018)
A recent publication describes a sophisticated “liquid biopsy” procedure that analyses both tumoral DNA and proteins present in peripheral blood to provide sensitive detection of different types of cancer. These results ...